The diabetes-prone NZO/Hl strain. Proliferation capacity of beta cells in hyperinsulinemia and hyperglycemia.

Document Type


Publication Date



Apoptosis, Cell-Proliferation, Diabetes-Mellitus-Type-1, Hyperglycemia, Hyperinsulinism, Immunohistochemistry, In-Situ-Nick-End-Labeling, Insulin, Insulin-Secreting-Cells, Islets-of-Langerhans, Ki-67-Antigen, Male, Mice-Mutant-Strains, Mice-Obese, Obesity

First Page


Last Page


JAX Location

see Reprint Collection

JAX Source

Arch Physiol Biochem 2006 Feb; 112(1):49-58.


New Zealand Obese (NZO) male mice develop a polygenic juvenile-onset obesity and maturity onset hyperinsulinemia. Approximately 50% transit to chronic hyperglycemia. Here we report on the proliferation of beta cells in relation to both the individual's metabolic status and structural parameters of the endocrine pancreas. Proliferating beta cells were quantified in pancreas sections by immunoenzymatic double staining of Ki-67 protein, as a marker for proliferating cells, and endocrine non-beta cells in order to distinguish them from beta cells. In normoglycemic NZO/Hl males Ki-67 labelling indices (IKi-67) of beta cells varied between 0.14 and 1.5%, and correlated significantly with both serum insulin levels and beta cell size. There was no correlation with the glycemic status. In diabetic males, beta cell size was increased. IKi-67 varied between 1 and 3%. The data suggest that the secretory activity of beta cells triggered by glucose, entailed changes in both beta cell hypertrophy and proliferation. As shown by morphometric measurements, beta cell expansion in diabetic mice was limited, in spite of high IKi-67 values. This suggested increased death rates of beta cells.

Please contact the Joan Staats Library for information regarding this document.